<DOC>
	<DOCNO>NCT01865968</DOCNO>
	<brief_summary>A phase IV , randomization , single center , control clinical trial compare safety , immunogenicity , three-year immune persistence inactivate hepatitis A vaccine ( HAV ) one- two-dose regimen live attenuate HAV one-dose regimen Chinese young adult , evaluate immunogenicity booster dose .</brief_summary>
	<brief_title>Comparison Immunogenicity Safety Inactivated Live Attenuated Hepatitis A Vaccines Young Adults</brief_title>
	<detailed_description>Healthy undergraduate student age 16 25 year anti-HAV negative randomly divide three group . Group A B administrate one-dose inactivated live attenuate hepatitis A vaccine respectively ; Group C immunize two dos inactivate vaccine 6 month apart . Blood sample collect month 1 , 12 , 24 36 anti-HAV titer determination . Safety observation 30 minute ' duration vaccination injection-site reaction systemic reaction three consecutive day record assess safety investigational vaccine . At Month 36 , subject receive one dose inactivate live attenuate HAV administrate booster dose take blood sample one month later anti-HAV titer determination .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy undergraduate student age 16 25 year Sign inform consent Provide ID Axillary temperature &gt; 37.0 centigrade time dose Subject medical history following : allergic history , allergic ingredient vaccine Serious adverse reaction vaccine anaphylaxis , hive , respiratory difficulty , angioedema , abdominal pain Autoimmune disease immunodeficiency Congenital malformation , developmental disorder serious chronic disease ( Down 's syndrome , diabetes , sickle cell anemia neurological disorder ) Bleeding disorder diagnose doctor ( e.g . factor deficiency , coagulopathy , platelet disorder require special precaution ) significant bruise bleed difficulty IM injection blood draws History family history convulsion , epilepsy , brain disease psychiatric History blood product within 3 month Administration investigational research agent within 30 day Administration live attenuate vaccine within 30 day Administration subunit inactivate vaccine within 14 day Any medical , psychiatric , social condition , occupational reason responsibility , judgment investigator , contraindication protocol participation impair volunteer 's ability give inform consent antiHBsAg positive antiHAV positive Pregnancy test result positive</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>inactivate HAV vaccine ; live attenuate HAV vaccine ; immunogenicity ; safety</keyword>
</DOC>